review of glp-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Those discontinuing GLP-1 medications rapidly

G

Breaking News in Hepatology: How Semaglutide Heals the Liver Weve known for a while that GLP-1 receptor agonists like semaglutide are game-changers for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Here's what you need to know.

When appetite drops, its...

To address the gap in class-wide comparative safety analyses beyond previous studies limited to single drugs or organ systems, this study systematically evaluated adverse events for all approved GLP-1 RAs to identify hidden risks and support clinical decision-making

Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)